Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 4/2020

01-08-2020 | Carpal Tunnel Syndrome | FELLOWS' CORNER

When you are the first-in-the-country fellow in a fellowship program that is as unheard of as the disease itself: cardiac amyloidosis fellowship

Author: Syed Bukhari, MD

Published in: Journal of Nuclear Cardiology | Issue 4/2020

Login to get access

Excerpt

“Success, in most circumstances, is the by-product of hard work and opportunity; the hardest part in the pursuit of success is the recognition of that opportunity. Sometimes opportunity does not knock at the door, it merely whispers.” …
Literature
1.
Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. 99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6:195–201.CrossRef
2.
Masri A, Bukhari S, Ahmad S, Nieves R, Eisele YS, Follansbee W, Brownell A, Wong TC, Schelbert E, Soman P. Efficient 1-hour technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis. Circ Cardiovasc Imaging. 2020;13:e010249.CrossRef
3.
Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardio. 2019;73:2872–91.CrossRef
Metadata
Title
When you are the first-in-the-country fellow in a fellowship program that is as unheard of as the disease itself: cardiac amyloidosis fellowship
Author
Syed Bukhari, MD
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 4/2020
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02131-2

Other articles of this Issue 4/2020

Journal of Nuclear Cardiology 4/2020 Go to the issue

Review of the Literature

Cardiovascular disease in the literature: A selection of recent original research papers

Original Article

Quantification of myocardial blood flow with 11C-hydroxyephedrine dynamic PET: comparison with 15O-H2O PET

LETTER TO THE EDITOR

99mTc-labelled bone tracer myocardial quantification: About correlation with heart function

WHAT IS THIS IMAGE?

What Is This Image? 2020: Image 1 Result

Review of the Literature

Nuclear cardiology in the literature: a selection of recent, original research papers

EDITORIAL

Refining practice: TID metrics for CZT systems

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits